EP1408907A4 - Dosage et conditionnement de medicaments a liberation controlee - Google Patents

Dosage et conditionnement de medicaments a liberation controlee

Info

Publication number
EP1408907A4
EP1408907A4 EP02731902A EP02731902A EP1408907A4 EP 1408907 A4 EP1408907 A4 EP 1408907A4 EP 02731902 A EP02731902 A EP 02731902A EP 02731902 A EP02731902 A EP 02731902A EP 1408907 A4 EP1408907 A4 EP 1408907A4
Authority
EP
European Patent Office
Prior art keywords
metering
packaging
controlled release
release medication
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02731902A
Other languages
German (de)
English (en)
Other versions
EP1408907A2 (fr
Inventor
Andrew L Abrams
Anand V Gumaste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microdose Therapeutx Inc
Original Assignee
Microdose Therapeutx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Therapeutx Inc filed Critical Microdose Therapeutx Inc
Publication of EP1408907A2 publication Critical patent/EP1408907A2/fr
Publication of EP1408907A4 publication Critical patent/EP1408907A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
EP02731902A 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee Withdrawn EP1408907A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
US294786P 2001-05-31
PCT/US2002/016185 WO2002096347A2 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Publications (2)

Publication Number Publication Date
EP1408907A2 EP1408907A2 (fr) 2004-04-21
EP1408907A4 true EP1408907A4 (fr) 2010-02-24

Family

ID=23134944

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02731902A Withdrawn EP1408907A4 (fr) 2001-05-31 2002-05-22 Dosage et conditionnement de medicaments a liberation controlee

Country Status (8)

Country Link
EP (1) EP1408907A4 (fr)
JP (1) JP2005514966A (fr)
AU (1) AU2002303840A1 (fr)
BR (1) BRPI0209720A2 (fr)
CA (3) CA2614899A1 (fr)
NZ (1) NZ529696A (fr)
WO (1) WO2002096347A2 (fr)
ZA (1) ZA200402466B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AR040672A1 (es) 2002-07-25 2005-04-13 Glaxo Group Ltd Forma de dosificacion farmaceutica multicomponenete, cuerpo apropiado para ser utilizado en la misma y procedimiento para prepararla
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
CA2625776A1 (fr) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Conditionnement pharmaceutique d'une combinaison posologique orale
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
SG10201810784SA (en) 2009-04-28 2018-12-28 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
MY187036A (en) 2010-01-05 2021-08-27 Microdose Therapeutx Inc Inhalation device and method
TWI638652B (zh) 2010-04-07 2018-10-21 波提亞斯數位康健公司 微型可攝取裝置
WO2012071280A2 (fr) * 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Dispositif ingérable avec produit pharmaceutique
WO2015112603A1 (fr) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Produit ingérable pouvant être mâché et système de communication associé
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
BR112015001388A2 (pt) 2012-07-23 2017-07-04 Proteus Digital Health Inc técnicas para fabricar marcadores de eventos ingeríveis que compreendem um componente ingerível
AU2013331417B2 (en) 2012-10-18 2016-06-02 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR102051875B1 (ko) 2016-07-22 2019-12-04 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 이벤트 마커의 전자기 감지 및 검출
AU2017348094B2 (en) 2016-10-26 2022-10-13 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
WO2001012103A1 (fr) * 1999-08-18 2001-02-22 Microdose Technologies, Inc. Mesure et conditionnement de medicaments a liberation controlee

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4808413B1 (fr) * 1987-04-28 1991-09-10 Squibb & Sons Inc
WO1999025374A1 (fr) * 1997-11-19 1999-05-27 Adir Et Compagnie Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
WO2001012103A1 (fr) * 1999-08-18 2001-02-22 Microdose Technologies, Inc. Mesure et conditionnement de medicaments a liberation controlee

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02096347A2 *

Also Published As

Publication number Publication date
BRPI0209720A2 (pt) 2017-06-13
WO2002096347A3 (fr) 2003-03-27
ZA200402466B (en) 2006-07-26
JP2005514966A (ja) 2005-05-26
CA2448997A1 (fr) 2002-12-05
CA2614899A1 (fr) 2002-12-05
NZ529696A (en) 2008-07-31
EP1408907A2 (fr) 2004-04-21
WO2002096347A2 (fr) 2002-12-05
CA2614902A1 (fr) 2002-12-05
AU2002303840A1 (en) 2002-12-09

Similar Documents

Publication Publication Date Title
EP1408907A4 (fr) Dosage et conditionnement de medicaments a liberation controlee
EP1367060A4 (fr) Derives glucopyranosyloxybenzylbenzene et leur utilisation medicale
EP1364957A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
EP1364958A4 (fr) Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HUP0401029A3 (en) Pack containing medicament and dispensing device
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
AU2003268015A8 (en) Packaging and dispensing of rapid dissolve dosage form
HUP0300409A3 (en) Pharmaceutical compositions containing antiadhesive carbohydrates and their use
HUP0301242A3 (en) Controlled release drug dosage form
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
HUP0303998A3 (en) Phthalazinones derivatives and pharmaceutical compositions containing them
EP1370135A4 (fr) Produits a liberation controllee et leurs procede de preparation
HRP20041193A2 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
EP1296660A4 (fr) Preparation d'insuline a liberation lente et procede de production associe
EP1501352A4 (fr) Methodes et compositions de liberation controlee de medicaments
AU2001232948A1 (en) Controlled release of drugs
GB0119848D0 (en) Delayed and sustained drug release
HK1064042A1 (en) Medicines and medicinal kits
PL367676A1 (en) Novel heterocyclic derivatives and medicinal use thereof
HUP0303799A3 (en) 5-membered heterocycles and application thereof as medicaments

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20031127

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MICRODOSE THERAPEUTX, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20100121

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/00 20060101ALI20100115BHEP

Ipc: A61K 9/48 20060101ALI20100115BHEP

Ipc: A61K 9/20 20060101AFI20100115BHEP

17Q First examination report despatched

Effective date: 20100806

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101217